Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indinol Forto vs Visanne in Endometriosis
NCT07164183Phase 3Recruiting
- Sponsor
- Alcea
- Start
- Sep 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indole-3-carbinol in endometriosis, sponsored by Alcea. Started Sep 2025; status: recruiting.
02
Drugs
indole-3-carbinol
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT07164183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07164183.